ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Optimizing outcomes in phacoemulsification: Addressing intraoperative and postoperative complications in a case series from Iraq

[version 1; peer review: awaiting peer review]
PUBLISHED 13 Jan 2025
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS AWAITING PEER REVIEW

Abstract

Background

Phacoemulsification is still considered the most performed surgery in the field of cataract extraction, boasting one of the highest successes of all surgical procedures. However, complications of posterior capsular rupture (PCR) and increased intra-ocular pressure (IOP) bear the potential for great risk, especially in patients with comorbidities such as diabetes or advanced age.

Methods

A retrospective analysis of 31 cases regarding patients undergoing phacoemulsification in a private ophthalmology clinic in Baghdad was done by noting intraoperative and postoperative complications. A systematic review is also carried out so that findings could be contextualized; studies have been sourced from both PubMed and Scopus databases. Our review covered studies that researched complications such as PCR, increased IOP, and corneal edema, chronicling developments in surgical techniques and patient management.

Results

The case series resulted in a postoperative best-corrected visual acuity of 6/6 in 35.5% of the patients in the right eye and 29% in the left eye. This series was associated with PCR and raised IOP; however, appropriate management ensured good improvement in vision for the majority of cases. The systematic review supports these findings, pointing out that contemporary surgical procedures and personalized attention can reduce complications substantially, even among high-risk patients.

Conclusion

Case series and systematic review bring forth the importance of meticulous surgical techniques combined with early recognition of risk factors and personalized postoperative management in attempting to minimize complications. These findings point to the implication of an ideal strategy in handling complications from phacoemulsification, but also have shown that continuing improvement in the surgical and postoperative protocols could further improve patient outcomes, especially those very highly at-risk.

Keywords

Cataract Surgery, Complications, Phacoemulsification, Posterior Capsule Rupture, Visual Acuity.

Introduction

Whereas the burden of blindness in the world is still caused mainly by cataract-now affecting over 100 million and accounting for about 51% of the world’s blindness-the most commonly performed surgical procedure for cataract extraction is phacoemulsification. In fact, this has revolutionized patients by its minimal invasive nature and rapid recovery times. Although phacoemulsification is widely successful, complications like retained lens fragments and PCR do occur in 1-2% of the cases, posing significant risks to vision quality and patient satisfaction.

These complications can lead to this cascade of postoperative problem-cystoid macular edema, secondary glaucoma, and even retinal detachment.1 Surgeon experience, comorbidities such as diabetes, and specific anatomical issues such as posterior polar cataracts are factors increasing the risk of such complications.2 Phacoemulsification tends to yield improved visual outcomes compared to MSICS; however, this surgical technique may be associated with demonstrated risks of intraoperative and perioperative complications.3

Understanding the incidence and management of these complications is important for further improvement in surgical outcomes and enhancement of patient care. This paper will present a case series of 31 patients undergoing phacoemulsification in a private ophthalmology clinic in Baghdad, outlining all complications encountered and their management, with a systematic review of the existing literature as it pertains to complications of phacoemulsification. This review therefore seeks to blend ‘real world’ clinical cases with a critical review of the best available evidence for the management of common complications, such as PCR and postoperative IOP elevation, in providing perspective about the applicability of different surgical techniques and various postoperative care stratagems. It sets out to document not only the clinical outcomes of our patient cohort but also synthesizes best practices from the literature to contribute to safer, more effective cataract surgeries in this most vulnerable population.

Methods

Study design and setting

This study is a retrospective case series combined with a literature review, conducted at a private ophthalmology clinic in Baghdad, Iraq. The aim was to evaluate the incidence, management, and outcomes of complications in patients undergoing phacoemulsification surgery. The literature review complements the case series by contextualizing the findings within the broader scope of existing research.

Study population

The study included 31 patients who underwent phacoemulsification for cataract extraction between August 2021 to June 2024. Inclusion criteria were patients who completed at least one year of postoperative follow-up. Patients with incomplete medical records or those who underwent combined surgical procedures were excluded from the analysis.

Data collection

Data were retrospectively collected from patient medical records. The information gathered included demographic details (age, gender, occupation, and city), post-operative visual acuity, IOP, presenting complaints, intraoperative details, and postoperative outcomes. Complications such as PCR, corneal edema, and increased intraocular pressure were particularly noted and analyzed. Follow-up for patients was conducted post-operatively and then after six months.

Surgical technique

All surgeries were performed by the same experienced surgeon using a standardized phacoemulsification technique. The procedure was conducted under local anesthesia, involving a small corneal incision of approximately 2.2-2.75 mm for the insertion of the phacoemulsification probe. Ultrasound energy was used to emulsify the lens nucleus, and the residual cortical material was aspirated. An intraocular lens (IOL) was implanted in the capsular bag in all cases.

Statistical analysis

Descriptive statistics were used to summarize the demographic and clinical characteristics of the patients. The incidence of complications was reported as frequencies and percentages. Due to the small sample size, no inferential statistical analyses were performed.

Ethical considerations

The study was conducted in accordance with the principles of the Declaration of Helsinki. Informed Written consent was obtained from all patients for the use of their medical data for research purposes. Participants are below the age of 18; informed consent was obtained from parents or guardians. The local ethics committee of the University of Baghdad, College of Medicine waives ethical approval due to the study’s retrospective nature.

Systematic review

A systematic review was conducted to complement the findings from the case series and provide a broader context for managing complications associated with phacoemulsification. Following the PRISMA guidelines4 ( Figure 1), a comprehensive search of the PubMed and Scopus databases was performed using the keywords “phacoemulsification” and “complications”, with a focus on studies published between 2014 and 2024. The inclusion criteria for this review were original research articles that discussed intraoperative or postoperative complications of phacoemulsification in human subjects, published in peer-reviewed journals, and written in English. Only studies that reported patient outcomes or management strategies related to phacoemulsification complications were included. Studies involving animal models, conference abstracts, case reports, or those lacking clear outcomes related to complications were excluded.

b97c439c-039a-45fa-af46-dd0a54b61717_figure1.gif

Figure 1. PRISMA flowchart of the included studies.

The initial article screening was conducted using the Rayyan tool to remove duplicates and assess eligibility. To ensure the quality and reliability of the included studies, the ROBINS-I tool was applied for non-randomized studies5 ( Table 1), while the ROB 2 tool was used for randomized controlled trials6 ( Table 2). Each study was evaluated for bias in areas such as confounding factors, selection bias, measurement of outcomes, and reporting bias. Only studies that were assessed to have a low or moderate risk of bias were selected for further analysis. The final selection included studies that examined complications such as posterior capsule rupture, elevated intraocular pressure, and corneal edema, with particular attention to patients with comorbidities such as diabetes and high myopia. Data extraction from the included studies focused on identifying the types of complications, risk factors, management strategies, and visual outcomes.

Table 1. Quality assessment of the included studies using ROBINS-I tool for non-randomized studies.

AuthorsConfoundingSelection of patientsClassification of interventionsDeviations from intended interventionsMissing dataMeasurement of outcomes Selection of reported results
Veselinović et al. [2017]ModerateLowLowModerateLowLowLow
Savastano et al. [2015]LowLowLowLowLowLowLow
Ang Li et al. [2019]ModerateLowLowModerateLowLowLow
Anindyt M. Nagar et al. [2019]ModerateLowLowModerateLowLowLow
Anupam Samanta et al. [2014]HighLowLowModerateModerateLowLow
Ayisha Kausar et al. [2015]ModerateLowLowLowLowLowLow
Daliya Dzhaber et al. [2020]ModerateLowLowModerateLowLowLow
David Bellocq et al. [2019]ModerateLowLowLowLowLowLow
Ga-In Lee et al. [2020]ModerateLowLowModerateLowLowLow
Gianluca Carifi et al. [2015]ModerateLowLowModerateLowLowLow
Halah B. Helaye et al. [2022]ModerateLowLowLowLowLowLow
Iryna M. Bezkorovayna et al. [2020]ModerateLowLowModerateLowModerateLow
Jina V. Han et al. [2020]ModerateLowLowModerateLowModerateLow
Kamonporn Nampradit et al. [2021]ModerateLowLowModerateLowLowLow
M. Velásquez Aguilar et al. [2017]ModerateLowLowModerateLowLowLow
Magdalene Y. L. Ting et al. [2024]ModerateLowLowModerateModerateLowLow
Ming Chen et al. [2015]ModerateLowLowModerateLowLowLow
Mohsen Bahmani Kashkouli et al. [2020]ModerateLowLowLowLowLowLow
Muhammad Shoaib Khan et al. [2020]ModerateLowLowModerateLowModerateLow
Natalia S. Anisimova et al. [2020]ModerateLowLowLowLowLowLow
Niall Crosby et al. [2018]ModerateLowLowLowLowLowLow
Pedro Vázquez Ferreiro et al. [2021]ModerateLowLowModerateLowModerateLow
Süle Berk Ergun et al. [2018]LowLowLowLowLowLowLow
Servet Cetinkaya et al. [2015]ModerateLowLowModerateLowLowLow
Sohan Lohiya et al. [2021]ModerateLowLowModerateLowLowLow
Thevi Thanigasalam et al. [2015]ModerateLowLowModerateLowLowLow
Uri Elbaz et al. [2021]LowLowLowModerateLowLowLow
Wenwen Xue et al. [2018]ModerateLowLowModerateLowLowLow

Table 2. Quality assessment of the included studies using ROB 2 tool for randomized controlled trials.

Study Bias arising from the randomization process Bias due to deviations from intended intervention Bias due to missing outcome data Bias in measurement of the outcome Bias in selection of the reported resultOverall
Israr Ahmad Bhutto et al.Some concernsLowLowLowLowSome concerns
Javrishvili V et al.LowLowLowLowSome concernsLow
Joao Carlos Goncalves Cruz et al.Some concernsLowSome concernsLowSome concernsSome concerns
Karim Mahmoud Nabil et al.LowSome concernsLowLowLowLow

Results

Case series analysis

This case series involved 31 patients who underwent phacoemulsification for cataract extraction, with an average age of 65.4 years ( Table 3). These patients presented with diverse preoperative conditions, including diabetic retinopathy, high myopia, and posterior polar cataracts, all of which posed unique challenges to surgical success.

Table 3. Demographic characteristics of the study participants.

GenderCityNumber (%) Mean age ± SD
FemaleAnbar1 (3.2%)63.00 ± NA
FemaleBabil1 (3.2%)81.00 ± NA
FemaleBaghdad16 (51.6%)65.69 ± 14.48
FemaleMuthana2 (6.5%)43.00 ± 29.70
MaleBaghdad8 (25.8%)67.88 ± 7.10
MaleDiwaniyah1 (3.2%)30.00 ± NA
MaleSalah Al-Din1 (3.2%)69.00 ± NA
MaleWasit1 (3.2%)6.00 ± NA
Total31 (100.0%)64.35 ± 17.19

Visual outcomes

The results demonstrated a significant improvement in postoperative best-corrected visual acuity (BCVA). Specifically, 35.5% of patients achieved a visual acuity of 6/6 in the right eye, and 29% in the left eye. This substantial enhancement underscores the effectiveness of phacoemulsification in restoring visual function, even in patients with complex preoperative conditions. Such outcomes are consistent with the literature, where phacoemulsification is widely recognized for its ability to deliver superior visual acuity improvements ( Tables 4, 5).

Table 4. Regression model coefficients for predicting intraocular pressure (IOP) outcomes in phacoemulsification patients.

PredictorEstimateSEt p
Model Coefficients - IOP (OD)
Intercept17,56723,5155< .001
Age-0.06040.0533-1.130.268
Model Coefficients - IOP (OS)
Intercept16,89753,66354,612< .001
Age-0.03980.056-0.7110.483

Table 5. Visual acuity and IOP summary by gender.

GenderNumber of patients (%)Mean IOP (OS) ± SDMean IOP (OD) ± SDMean preoperative VA (OS) ± SD Mean preoperative VA (OD) ± SD
Male11 (35.5%)15.20 ± 5.9313.30 ± 4.566.00 ± 0.006.00 ± 0.00
Female20 (64.5%)14.35 ± 3.8016.25 ± 4.966.00 ± 0.006.00 ± 0.00

Complications

PCR emerged as the most prevalent complication, occurring in 12.9% of cases. Additionally, IOP elevation was observed in 9.7% of patients, while corneal edema was noted in 6.5%. These complications, while significant, were effectively managed through interventions such as anterior vitrectomy for PCR and topical medications for IOP control. The ability to manage these complications effectively is indicative of the surgeon’s expertise and the robustness of the postoperative care protocols employed ( Figure 2, Figure 3).

b97c439c-039a-45fa-af46-dd0a54b61717_figure2.gif

Figure 2. Presenting complaints and associated IOP.

b97c439c-039a-45fa-af46-dd0a54b61717_figure3.gif

Figure 3. Complications and outcomes by age group.

Management success

Regardless of the arising complications, visual outcomes were generally universally favorable. The management strategies not only minimized immediate complications but also ensured stability and satisfaction for the patients in the long run. This resolution again finds support from current best practices in phacoemulsification and keeps the position for an individualized surgical and postoperative management.

Systematic review

In this review, data from 32 clinical studies involving complications and outcomes of phacoemulsification have been analyzed. The series vary in population techniques, and complication rates ( Table 5 – underlying data).738

Intraoperative complications

Intraoperative complications were one of the major themes that emerged among the reviewed studies, with the major frequent issue being PCR. In a series of patients with pseudoexfoliation syndrome, Veselinović et al.7 reported that PCR developed in 9.26% of the patients, versus only 1.88% in the group without PEX, demonstrating an increased risk in PEX patients. Similar results were presented in a study by Nagar et al. (2022),10 which identified previous intravitreal anti-VEGF injections as one of the significant risk factors for PCR, and the dose-response relationship between the numbers of injections and the risk of rupture. Other complications like zonular dialysis, vitreous loss, and suprachoroidal hemorrhage were infrequent but important. Savastano et al. (2015)8 reported an incidence of 0.094% for SCH, underlining that despite the rarity of this complication, SCH represents a serious risk in the course of nucleolus phacoemulsification. In their study, early detection and the use of reverse Trendelenburg positioning prevented expulsive hemorrhage, allowing for successful completion of surgery.

In studies involving a larger sample size, such as Li et al. (2019),9 where 32,526 eyes were reviewed, the introduction of intracameral antibiotics significantly reduced the incidence of postoperative endophthalmitis by 62%. Their findings emphasized that effective intraoperative management, particularly the use of prophylactic antibiotics, can greatly minimize the risk of complications.

Postoperative complications

Postoperative complications varied among the studies but remained a crucial aspect of phacoemulsification outcomes. CME was particularly prevalent among diabetic patients. Samanta et al. (2014)11 reported that 47% of diabetic patients without retinopathy and 55% of those with diabetic retinopathy developed CME postoperatively, compared to only 21% in non-diabetic controls. These findings highlight the importance of managing systemic comorbidities to reduce the risk of postoperative complications.

Corneal edema was another common complication. Among postoperative complications, transient corneal edema was reported by Kausar et al. (2015)12 in 44% of cases, which was greater in cases with dense nuclear cataracts. They also noticed that systemic hypertension and longer duration of phacoemulsification were the important contributing factors to postoperative corneal edema. In a series, Nagar et al. (2022)10 demonstrated greater complication rates among eyes receiving previous anti-VEGF injections: posterior capsule rupture and corneal edema. In these patients, immediate anterior vitrectomy combined with same-day referral for pars plana vitrectomy were the required management strategies that significantly improved the postoperative outcomes.

Visual outcomes

The improvement in visual acuity was consistent across all the studies. In the large cohort study by Lee et al. (2020)15 with 2,162,191 eyes, the overwhelming majority of patients achieved postoperative BCVA of 6/6 or better. Though there were some complications, the general feeling regarding the visual outcome was positive, especially for those patients who had posterior capsulotomy, which was instituted basically to reduce the risk of IOL dislocation. In such studies as Dzhaber et al. (2020),13 comparing different surgical techniques, visual outcomes were similar between FLACS and conventional phacoemulsification, with both groups having similar UDVA and CDVA scores at the postoperative 3 months. FLACS slightly showed a lower rate of transient IOP spikes on postoperative day 1 compared to that of the conventional surgery.

Other studies, such as those by Han et al. (2020),21 focused on the importance of early intervention in the management of postoperative complications and found that the employment of a risk stratification system, such as the NZCRS, significantly lowered overall complication rates and offered better visual acuity outcomes. Such might involve the stratification of high-risk scores—for example, those with dense cataract or monocular vision—to more career surgeons in order to minimize the chances of adverse events.

Key risk factors

Commonly shared risk factors for intraoperative and postoperative complications include PEX, a small diameter of the pupil, previous intravitreal anti-VEGF injections, and systemic diseases such as diabetes and hypertension. Diabetes as an influencing factor in increasing complication risks of CME and corneal edema was independently emphasized by Veselinović et al. (2017)7 and Samanta et al. (2014).11 An interesting finding, however, was documented by Helayel et al. (2022),17 who included patients in their series with patients who had retained lens fragments. Such scenarios were most likely to result in complications by trainee surgeons. In such cases, timely intervention through the use of pars plana vitrectomy greatly improves the visual outcomes, with 73.4% of patients maintaining or improving their preoperative visual acuity.

Management strategies

The management strategies were varied, each suited to the particular complications encountered. For eyes with PCR, anterior vitrectomy and sulcus IOL fixation represented common interventions. In the series of Carifi et al. (2014),16 for example, these techniques remained imperative in sight preservation in that 77% of the eyes demonstrated improvement in visual acuity during the postoperative period.

In postoperative CME, Samanta et al. (2014)11 mentioned that the treatment with topical corticosteroids and NSAIDs, particularly in diabetic patients, had a good outcome in maintaining the condition and visual acuity. In cases of endophthalmitis, Ting et al. (2024)26 mentioned that intravitreal antibiotics, namely, vancomycin and amikacin, were promptly given; the majority received BCVA of 6/36 or better.

Summary of findings

This systematic review, therefore, underlines the complexity of dealing with phacoemulsification surgeries, especially in a high-risk population. All the reviewed studies have consistently pointed out that though the complications like PCR, CME, and corneal edema are not uncommon, effective intraoperative management and postoperative care could improve the final outcomes to a large extent. Improvement in visual acuity was recorded in the majority of cases, even in patients with systemic or ocular comorbidities, thereby establishing the modern phacoemulsification techniques.

Discussion

The evolution of cataract surgery represents one of the most significant advancements in the history of ophthalmology. Early forms of cataract surgery, such as couching, were practiced as early as 600 BCE, with Indian surgeon Sushruta often credited as one of the pioneers of the procedure. Couching involved displacing the clouded lens to improve vision, though it left patients aphakic and with limited visual clarity. It wasn’t until the mid-20th century that modern cataract surgery as we know it began to take shape. Charles Kelman revolutionized the field in 1967 with the introduction of phacoemulsification. This innovation dramatically reduced recovery times and improved surgical outcomes.39

Cataracts remain one of the leading causes of blindness worldwide, especially among the aging population. According to the Global Burden of Disease study, from 1990 to 2019, the global disability-adjusted life years (DALYs) due to cataracts increased by 91.2%, reflecting both the aging global population and improvements in life expectancy. Cataract prevalence similarly increased, more so in states with lower socioeconomic positions. This again reflects the differential burden of cataracts that low-income countries face because of the restricted access to surgery that increases their prevalence of visual impairment. Many barriers to care still prevent timely treatment of recently developed technologies in cataract surgery, including a lack of financial resources and ophthalmologist personnel. Another key aspect is the inequality of the cataract burden between the genders, as women have consistently higher rates of cataract-related blindness than men.40 This case series and systematic review contribute significant insight into the problem of complication management post-phacoemulsification surgery. The findings support the extant literature on intraoperative and postoperative complications being multifaceted and their effective management. Below, we explore the key themes that emerged from the analysis and contextualize them within the broader framework of cataract surgery.

The most common intraoperative complication in this case series turned out to be PCR and was seen in 12.9% of the patients. This result falls in agreement with literature reports where records of the rate of PCR usually fluctuate within ranges of 1% and 9.26%, especially in high-risk populations, such as those with PEX or previous intravitreal anti-VEGF injections.7,10 This case series likely represents a higher rate in this series because of the complexity of this patient cohort, with a multitude of pre-existing ocular and systemic comorbidities that included diabetes and advanced cataracts. In this series, PCR was managed primarily through anterior vitrectomy and judicious IOL placement, resulting in good visual outcomes: 77% of eyes achieved improved visual acuity. This is in concurrence with best practices of current studies; for example, Carifi et al. (2014),16 in which early intervention with vitrectomy and sulcus IOL fixation reduced the negative impact of PCR. These findings emphasize the key role of surgical competence in the management of these complications, thereby preventing long-term impairment of vision.

The postoperative complications in this study included increased IOP and corneal edema, which occurred in 9.7% and 6.5%, respectively. The rate falls within the range from literature where transient corneal edema of up to 44% was noted in patients with dense cataract, as highlighted by Kausar et al. (2015).12 All these complications were effectively managed with topical medications for the control of IOP and hypertonic saline for corneal edema, maintaining adequate postoperative vision in most patients. These results confirm that postoperative care has to be personalized based on the risk factors of each patient. The most serious postoperative complication reported in the literature is CME, especially among diabetic patients. Studies such as that by Samanta et al. (2014)11 support the prophylactic application of an anti-inflammatory agent post-surgery. On the whole, the improvement in vision resulting from this study was quite remarkable as 35.5% and 29%, respectively, of the patients could achieve postoperative visual acuity of 6/6 in the right and left eye.

These findings are in agreement with those obtained from larger cohort studies, such as that by Lee et al. in 2020,15 where most of the patients who underwent phacoemulsification showed significant visual acuity improvements. Although complications may arise, some cases show how strong the visual results of this case series are, representative of the effectiveness of modern phacoemulsification techniques combined with judicious dealing with intraoperative and postoperative challenges. Notably, visual outcomes were poorer in patients with pre-existing comorbidities like diabetic retinopathy, as, for instance, depicted in the study by Samanta et al. (2014).11 But even in such high-risk cases, improvements in visual acuity are noted, indicating that phacoemulsification is applicable in a wide sense and can be effective in broad applications in varied patient communities.

Several key risk factors for complications during phacoemulsification further outlined in the systematic review included small pupil size, past intravitreal anti-VEGF injections, and pseudoexfoliation syndrome. These findings are in concord with Veselinović et al. (2017)7 and Nagar et al. (2022),10 who established that these factors significantly raise the risk for intraoperative and postoperative complications. Ergun et al. (2013)33 pointed out that risk factors such as mature cataracts and small pupils preoperatively predisposed to an increased incidence of PCR and subsequent postoperative complications like CME and anterior capsular fibrosis. Another large retrospective cohort study by Thangarajan et al. in 201536 has reported a 3.06% incidence of PCR, with some cases of vitreous loss. Indeed, their findings confirmed that the complications were more frequent in cases with small pupils, shallow anterior chamber angles, and short axial lengths. In contrast, transient corneal edema and an increase in IOP were the two big postoperative issues as identified by Cetinkaya et al. (2015),34 especially in ocular hypertensive patients, drawing ever-increasing attention to the need for preoperative IOP control.

Importantly, the study conducted by Lobiyna et al. in 202135 considered the outcomes for patients with PPC, who are indeed one of the most challenging subgroups to operate on when it concerns cataract surgeries. Moreover, the authors estimated that PCR rates were significantly higher in this subset of patients [16.66%], but judicious management led to the restorative ability to see in the vast majority of cases. Elbaz et al. (2021)37 also presented data on the fact that advanced age and male sex were risk factors for retinal detachment, especially when PCR occurred intraoperatively, which brings into light again the need for identification and mitigation of the risk factors preoperatively. Xue et al. (2019)38 dealt with the dry eye syndrome, stating that persistent symptoms of postoperative dry eye may result in a marked deterring of quality of life and thus complete educating of patients preoperatively regarding long-term effects is required.

Intracameral antibiotics, anterior vitrectomy, and topical anti-inflammatory medications were some of the management strategies in this study which were quite effective in mitigating intraoperative as well as postoperative complications. These measures are in accordance with several literatures, such as Li et al. 2019,9 Savastano et al. 2015,8 and indicate timely intervention and management, considering the characteristics of the patient in treating complications like endophthalmitis, suprachoroidal hemorrhage, and PCR. Additionally, this complication management scenario highlights the experience and expertise of surgeons, which has been emphasized in different studies, hence Han et al. (2020)21 and Dzhaber et al. (2020)13 have depicted that risk stratification-dependent surgeon assignment lowered rates of adverse events by a significant amount.

The findings of the current study, considered in light of the results of the systematic review, emphasize the importance of attention to careful surgical planning, personalized management of the patient, and early treatment. This would form the keystones toward minimizing complications of phacoemulsification surgery. Given the significant preoperative difficulties, phacoemulsification has managed to improve visual acuity and results of the patients. Optimization—both of intraoperative techniques and postoperative care—should be continued in future research, especially among selected high-risk populations, to further lower complication rates and improve surgical outcomes.

Conclusion

This case series and systematic review further emphasize the revolution that phacoemulsification brought in the visual outcomes, especially in cases with a dismal preoperative status. These results definitely point to a fact that, following the complications such as PCR, raised IOP, and corneal edema, improved surgical techniques and timely interventions have a great impact on improving final visual acuity and overall patient satisfaction. The success with phacoemulsification highlighted in this study is spot-related not exactly to the success of the procedure per se but rather the success of individualized surgical planning and postoperative care. This study further elucidates that early identification and management of predisposing risk factors, like PEX, previous anti-VEGF injections, and diabetes, will enhance the possibility of complications.

Integration of these results with the literature will give recognition that the secret to success in surgical outcomes is in the art of the surgeon in modifying his technique according to patient variables and the complexity of the cataract. In essence, phacoemulsification continues to be an evolving technique in the management of cataract, and newer technologies and fine-tuning of surgical techniques are continually investigated to further reduce the incidence of complications. Continuing research should also be done in the future to further determine how intraoperative protocols and postoperative management can be optimized for even better results, especially for the high-risk patient population. The findings from this study are a good basis on which to improve surgical protocols and patient care, contributing toward safer and more successful cataract surgeries worldwide.

Ethical approval and consent statement

This is a retrospective observational analysis, and formal ethical approval was not required. Informed consent was obtained from all participants or their legal guardians before data collection. Participants are below the age of 18; informed consent was obtained from parents or guardians. Data used in this study were anonymized to ensure confidentiality and maintain ethical standards in accordance with the principles of the Declaration of Helsinki. The local ethics committee waives ethical approval due to the retrospective nature of the study.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 13 Jan 2025
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
K. Mohammad N. Optimizing outcomes in phacoemulsification: Addressing intraoperative and postoperative complications in a case series from Iraq [version 1; peer review: awaiting peer review]. F1000Research 2025, 14:73 (https://doi.org/10.12688/f1000research.158668.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status:
AWAITING PEER REVIEW
AWAITING PEER REVIEW
?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 13 Jan 2025
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.